183 related articles for article (PubMed ID: 25397406)
1. Up-regulation of nerve growth factor in cholestatic livers and its hepatoprotective role against oxidative stress.
Tsai MS; Lin YC; Sun CK; Huang SC; Lee PH; Kao YH
PLoS One; 2014; 9(11):e112113. PubMed ID: 25397406
[TBL] [Abstract][Full Text] [Related]
2. Nerve growth factor induced farnesoid X receptor upregulation modulates autophagy flux and protects hepatocytes in cholestatic livers.
Tsai MS; Lee HM; Huang SC; Sun CK; Chiu TC; Chen PH; Lin YC; Hung TM; Lee PH; Kao YH
Arch Biochem Biophys; 2020 Mar; 682():108281. PubMed ID: 32001246
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor upregulates sirtuin 1 expression in cholestasis: a potential therapeutic target.
Tsai MS; Lee PH; Sun CK; Chiu TC; Lin YC; Chang IW; Chen PH; Kao YH
Exp Mol Med; 2018 Jan; 50(1):e426. PubMed ID: 29328070
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome analysis reveals a positive role for nerve growth factor in retinol metabolism in primary rat hepatocytes.
Kao YH; Lee PH; Chiu TC; Lin YC; Sun CK; Chen PH; Tsai MS
Cytokine; 2018 Jul; 107():74-78. PubMed ID: 29217403
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats.
Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ
J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498
[TBL] [Abstract][Full Text] [Related]
6. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
Li Z; Mizuno S; Nakamura T
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling in whole liver of bile duct ligated rats: VEGF-A expression is up-regulated in hepatocytes adjacent to the portal tracts.
Tanaka A; Tsuneyama K; Mikami M; Uegaki S; Aiso M; Takikawa H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1993-2000. PubMed ID: 17914982
[TBL] [Abstract][Full Text] [Related]
8. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
[TBL] [Abstract][Full Text] [Related]
9. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats.
Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S
J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302
[TBL] [Abstract][Full Text] [Related]
10. Glechoma hederacea extracts attenuate cholestatic liver injury in a bile duct-ligated rat model.
Wang YY; Lin SY; Chen WY; Liao SL; Wu CC; Pan PH; Chou ST; Chen CJ
J Ethnopharmacol; 2017 May; 204():58-66. PubMed ID: 28416441
[TBL] [Abstract][Full Text] [Related]
11. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
12. Taurocholate Induces Connective Tissue Growth Factor Expression in Hepatocytes Through ERK-YAP Signaling.
Yu B; Jin GN; Ma M; Liang HF; Zhang BX; Chen XP; Ding ZY
Cell Physiol Biochem; 2018; 50(5):1711-1725. PubMed ID: 30384360
[TBL] [Abstract][Full Text] [Related]
13. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
Song M; Song Z; Barve S; Zhang J; Chen T; Liu M; Arteel GE; Brewer GJ; McClain CJ
J Pharmacol Exp Ther; 2008 May; 325(2):409-16. PubMed ID: 18299419
[TBL] [Abstract][Full Text] [Related]
14. Melatonin attenuates oxidative stress, liver damage and hepatocyte apoptosis after bile-duct ligation in rats.
Aktas C; Kanter M; Erboga M; Mete R; Oran M
Toxicol Ind Health; 2014 Oct; 30(9):835-44. PubMed ID: 23095487
[TBL] [Abstract][Full Text] [Related]
15. Endogenous opioids modulate hepatocyte apoptosis in a rat model of chronic cholestasis: the role of oxidative stress.
Payabvash S; Kiumehr S; Nezami BG; Zandieh A; Anvari P; Tavangar SM; Dehpour AR
Liver Int; 2007 May; 27(4):538-47. PubMed ID: 17403194
[TBL] [Abstract][Full Text] [Related]
16. Changes in expression and immunolocalization of protein associated with toxic bile salts-induced apoptosis in rat hepatocytes.
Oh SH; Yun KJ; Nan JX; Sohn DH; Lee BH
Arch Toxicol; 2003 Feb; 77(2):110-5. PubMed ID: 12590363
[TBL] [Abstract][Full Text] [Related]
17. Platycodin D attenuates bile duct ligation-induced hepatic injury and fibrosis in mice.
Kim TW; Lee HK; Song IB; Lim JH; Cho ES; Son HY; Jung JY; Yun HI
Food Chem Toxicol; 2013 Jan; 51():364-9. PubMed ID: 23116642
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis.
Lee TY; Lee KC; Chang HH
Apoptosis; 2010 Aug; 15(8):904-14. PubMed ID: 20446039
[TBL] [Abstract][Full Text] [Related]
19. Yin-Chen-Hao-Tang ameliorates obstruction-induced hepatic apoptosis in rats.
Lee TY; Chang HH; Wu MY; Lin HC
J Pharm Pharmacol; 2007 Apr; 59(4):583-90. PubMed ID: 17430643
[TBL] [Abstract][Full Text] [Related]
20. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
